APRE
Aprea Therapeutics·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
APRE fundamentals
Aprea Therapeutics (APRE) released its earnings on Aug 12, 2025: revenue was 118.11K (YoY -78.97%), beat estimates; EPS was -0.53 (YoY +8.62%), beat estimates.
Revenue / YoY
118.11K
-78.97%
EPS / YoY
-0.53
+8.62%
Report date
Aug 12, 2025
EPS
Revenue
Revenue & Expenses
APRE has released its 2025 Q3 earnings report, with revenue of 1.85K, reflecting a YoY change of -99.48%, and net profit of -2.97M, showing a YoY change of 21.44%. The Sankey diagram below clearly presents APRE's revenue sources and cost distribution.
Key Indicators
Aprea Therapeutics (APRE) key financial stats and ratios, covering profitability, financial health, and leverage.
Aprea Therapeutics (APRE)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Aprea Therapeutics (APRE)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Aprea Therapeutics (APRE)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Aprea Therapeutics (APRE) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Aprea Therapeutics (APRE) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What is the revenue and EPS growth rate for Aprea Therapeutics year over year?What is Aprea Therapeutics's latest dividend and current dividend yield?What does Aprea Therapeutics do and what are its main business segments?What is the market's earnings forecast for Aprea Therapeutics next quarter?What were the key takeaways from Aprea Therapeutics's earnings call?What factors drove the changes in Aprea Therapeutics's revenue and profit?What is Aprea Therapeutics's gross profit margin?What were the key takeaways from Aprea Therapeutics’s earnings call?
